By: IPP Bureau
Last updated : May 17, 2022 5:16 pm
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
Sahajanand Medical Technologies bagged the National Technology Award 2022 for Supraflex Cruz - Sirolimus Eluting Coronary System.
Speaking at the National Technology Day 2022 event, which coincides with India becoming a full Nuclear Country after the Nuclear explosion at Pokhran on 11th May, 1998, Dr Jitendra Singh said, “India is already on the ascent and Science, Technology and Innovation are going to be the key determinants of the roadmap for next 25 years when we celebrate 100 years of India’s Independence.”
The awards were given by the Technology Development Board (TDB), a statutory body of Government of India functioning under the Department of Science of Technology for the year 2021-22. The winners were selected from a total 390 applications after a thorough examination by eminent technologists and a stringent two-tier evaluation process. The winners have been selected under the categories --Indigenous Technologies, MSME, Startups, and Women Scientists in Translational Research and Women Entrepreneurs. Dr S. Chandrasekhar, Secretary, DST and Rajesh Kumar Pathak, IP&TAFS, Secretary TDB were Guests of Honours.
“These awards conferred to various industries provides a platform of recognition to Indian industries and their technology provider, who have worked as a team, to bring innovation to the market and contributed to the vision of “Aatma Nirbhar Bharat”," said Rajesh Kumar Pathak, IP&TAFS, Secretary, Technology Development Board.
‘Supraflex Cruz’ is a Drug Eluting Coronary Stent with features such as low strut thickness (60 microns across all diameters), biodegradable polymer and is offered in many sizes. It is considered to be the “most deliverable” stent. Deliverability implies high ‘ease of use’ for implanting physicians in deploying a stent into complex arteries. Supraflex Cruz has been implanted in more than 400,000 patients globally as of March 31, 2021.
Accepting the honour Bhargav Kotadia, Managing Director, Sahajanand Medical Technologies said, “We are proud to receive this coveted award from the Government of India, recognising SMT’s position as a leading technology provider in the vascular device’s domain globally. Since its inception SMT has followed its motto ‘Pledged to Save Millions’, and with our unique and rigorously tested products.”